# To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients

> **NCT00489229** · PHASE3 · COMPLETED · sponsor: **Universiti Sains Malaysia** · enrollment: 66 (actual)

## Conditions studied

- Diabetes
- Impaired Glucose Tolerance

## Interventions

- **DRUG:** Rosiglitazone
- **DRUG:** Ramipril

## Key facts

- **NCT ID:** NCT00489229
- **Lead sponsor:** Universiti Sains Malaysia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2009-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489229, "To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00489229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*